Skip to content

L’Institut Servier Research Grants are awarded for one year of research, enabling:

  • French researchers, future PhDs or postdocs in medicine or pharmacy wishing to acquire additional training and/or supplement their research project abroad.
  • Or foreign researchers, future PhDs or postdocs wishing to supplement their training in France, with priority given to the following therapeutic areas: oncology, immuno-inflammatory diseases, neurodegenerative diseases, and paediatric diseases.

Eligibility criteria:

  1. Reason for the mobility and why it is necessary
  2. Candidate’s scientific studies and publications
  3. Project utility, relevance and scientific quality
  4. Candidate’s personal implication in the project
  5. Added value for the research team
  6. Candidate’s plans for further study after project completion

Terms and conditions

Grant Winners of the October 2022 session

Thomas BARBA

  • Research Project: «Meta-lune: Meta-learning in the management of Lupus Nephritis».
  • Host laboratory: Pr Olivier GEVAERT, Stanford Center for Biomedical Informatics Research, Stanford, USA.


  • Research Project: «Endpoints in marginal zone lymphomas: evaluation of a surrogate marker for PFS and assessment of emerging prognostic markers».
  • Host laboratory:  Pr Jim CERHAN, Mayo Clinic, Rochester, USA.

Guillaume BONNET

  • Research Project: «CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry (CHOICE-MI)».
  • Host laboratory: Pr J. GRANADA, Cardiovascular Research Foundation, New York, USA.

Caroline BOUCHE

  • Research Project: «Impact of adipocyte “browning” on the immune component of breast cancer: a new obesity-cancer link».
  • Host laboratory: Dr Daniela QUAIL, Université McGill, Institut du Cancer Rosalind et Morris Goodman, Montréal, Canada.

Aleksandra CHUDINOVA

  • Research Project:  «Analyze the role of p38a MAP kinase in the homeostatic neuronal regeneration in children with chemotherapy-induced neuropathy».
  • Host laboratory: Pr Miriam GOODMAN, Stanford University, Stanford, USA.


  • Research Project: «Enhancing chimeric antigen receptor (CAR) T-cell therapy-mediated anti-tumoral immunity: role of Natural Killer cells».
  • Host laboratory: Pr Rizwan ROMEE, Dana Farber Cancer Institute, Boston, USA.


  • Research Project: «Spatial characterization of the dynamic changes in early triple negative breast cancer patients treated by neodjuvant chemotherapy plus PD1 blockade».
  • Host laboratory: Pr Kai Wucherpfennig, Dana-Farber Cancer Institute, Boston, USA.


  • Research Project: «Characterization of PTPN22 function and its regulation in human B cells»
  • Host laboratory: Pr Eric MEFFRE, Stanford Medical School, Stanford, USA.


  • Research Project: «Augmented Interventional Oncology».
  • Host laboratory: Pr Bradford WOOD, NIH Center for Interventional Oncology, Bethesda, USA.